sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 concerning its interests in Mural Oncology plc, aligning with Rule 8.3 of the Irish Takeover Panel Act, 1997. As of May 5, 2025, The Vanguard Group holds a 4.47% interest in Mural Oncology, equating to 772,651 ordinary shares.
No new options or derivative transactions related to this investment have been made, and there are no associated agreements, arrangements, or understandings. This disclosure does not involve other parties or exempt fund manager connections, focusing solely on interests in Mural Oncology plc.
With no additional attachments or dealings reported, this disclosure is intended to inform stakeholders of The Vanguard Group's position within the scope of ongoing market operations.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.